One Time. For a Lifetime.
Protection against stroke risk. Protection against oral anticoagulant (OAC) bleed risk.
The WATCHMAN FLX Implant is the one-time, minimally invasive procedure that protects your atrial fibrillation patients for life.
Over 400,000 Afib patients have left blood thinners behind with WATCHMAN LAAC Devices1
Designed to treat a broad range of patient types
Protect your patients: Stroke risk reduction without the risks of OACs
Learn more about the WATCHMAN Implant and hear from cardiologists on this safe, OAC alternative for stroke risk reduction.
Learn more about WATCHMAN FLX
* Procedure success defined as successful delivery and release of a WATCHMAN FLX device into the LAA** Occurrence of one of the following events between the time of implant and within 7 days following the procedure or by hospital discharge, whichever is later: all-cause death, ischemic stroke, systemic embolism, or device or procedure related events requiring open cardiac surgery or major endovascular intervention.
- Represents all WATCHMAN models, including WATCHMAN FLX Devices.
- Kar, S., et al, Primary Outcome Evaluation of the Next Generation LAAC Device: Results from the PINNACLE FLX Trial, Circulation, 2021.